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Abstract
This paper presents the primary causes of false positive reactions for syphilis and describes clinical cases of patients with false-positive 
serological reactions.  The data suggest that positive reactions to either the nontreponemal or the treponemal test do not always indicate the 
presence of syphilis.
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Ложноположительные реакции на сифилис – проблема в медицинской практике
В работе рассмотрены основные причины ложноположительных реакций на сифилис (ЛПРС) и представлено описание клинических 
случаев острых ЛПРС у пациентов с различными заболеваниями.  На основании собственных данных высказывается мнение, что 
положительные трепонемные и нетрепонемные реакции не всегда свидетельствуют о наличии сифилиса.
Ключевые слова: сифилис, ложноположительные реакции на сифилис, иммуноблотинг.
In the Republic of Moldova, syphilis is still a great public 
health problem.  The World Health Organization estimates 
that there are approximately 12 million new cases of syphilis 
in adults worldwide.  The vast majority of these are seen in 
developing nations, but an increase in new cases has also 
been noted in Eastern Europe since the dissolution of the 
Soviet Union.
Laboratorial diagnosis of syphilis is crucial to the epide-
miological and diagnostic evaluation of the disease.  Syphilis 
has several clinical manifestations, making laboratory testing 
a very important aspect of diagnosis.  Despite several advan-
ces in key areas, the management of patients with syphilis 
remains difficult and controversial (8, 10).  In the Republic 
of Moldova, many unsuspected cases are discovered by labo-
ratory testing. 
The serologic detection of specific antibodies to T. pal-
lidum is of particular importance in the diagnosis of syphilis, 
since the natural course of the infection is characterized by 
periods of latency.  Latent syphilis can only be diagnosed 
by serological tests. In fact, in the Republic of Moldova the 
majority of syphilis cases are identified at the latent stage by 
serological tests (55%).  The etiological agent, Treponema 
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pallidum, cannot be cultured, and there is no single optimal 
alternative test.
The complexity of syphilis serology means that the 
services of reference laboratories and clinical experts are 
often needed.  Therefore, the laboratorial diagnosis is per-
formed mainly by serological tests, which are divided into 
nontreponemal tests for screening and treponemal tests for 
confirmation.  The nontreponemal tests include the Venereal 
Disease Research Laboratory (VDRL), RPR (Rapid plasma 
reagin) which is useful for screening and evaluation of treat-
ment responses.
Treponemal tests are used to confirm the diagnosis and 
include hemagglutination assay (TPHA), fluorescent trepone-
mal antibody absorption (FTA-ABS) as well as enzyme-linked 
immunosorbent assay (ELISA), and to detect specific anti-tre-
ponemal antibodies.  All nontreponemal tests measure both 
immunoglobulin IgG and IgM antiphospholipid antibodies, 
formed by the host in response to lipoidal material released by 
damaged host cells early in infection, and lipids from the cell 
surfaces of the treponem itself.  All treponemal tests use Tr. 
pallidum or its components as the antigen.  If lesion exudate or 
tissue is available, direct examination is performed, followed 
by a nontreponemal serology test.  A reactive nontreponemal 
test is then confirmed by a treponemal test.  A confirmed 
serological test result is indicative of the presence of trepo-
nemal antibodies but does not indicate the stage of disease, 
and depending on the test, it may not differentiate between 
past and current infection.  The sensitivity and specificity of 
serological tests vary depending on the type of test and stage 
of the disease.
All of the serologic tests for syphilis have been shown 
to possibly give false results when several different condi-
tions are present: other spirochetal diseases, autoimmune 
disorders or human immunodeficiency virus infection. 
Consequently, the use of a single method is considered 
insufficient to achieve the best diagnostic performance, 
and the quest for new, simple, reliable and money-saving 
diagnostic methods continues.  In theory, a confirmatory 
serologic test should have at least equivalent sensitivity, 
but greater specificity, than the screening test that uses a 
different methodology (4, 11).
Nontreponemal tests are widely available, rapid, in-
expensive and are necessary for determining the efficacy of 
treatment or confirming the reinfection.  There are, however, a 
number of limitations associated with nontreponemal tests:
• First, they lack sensitivity in late stage of infection: 30% of
patients with late latent or late active syphilis will show a
non-reactive result.
• Secondly, 1-2% of patients with secondary syphilis exhibit
a prozone reaction.  Prozone occurs when an excess of
antibody in undiluted serum inhibits flocculation with
the antigen, giving rise to weakly reactive, atypical or
occasionally false negative results.
• Finally, antibodies detected by nontreponemal tests are
not only produced as a consequence of treponemal in-
fection, but also in response to other conditions where
tissue damage occurs.
Because nonspecific or false-positive reactions occur 
with the nontreponemal tests, usually as a result of damage to 
the host’s tissue by infection, immunization or autoimmune 
disease, the search for a specific serologic test for syphilis 
continues.  The incidence of false-positive reactions depends 
on the test used and the population studied (1, 4).  Therefore, 
false-positive nontreponemal test reactions can have multiple 
causes, their incidence is generally 1% to 3% (6, 8).  The rate 
of false-positive tests during pregnancy is greater than that 
seen in the general population.  Additionally, as many as 28% 
of positive RPR results in pregnant women are biological 
false positives (13).  It is also about 10% higher among intra-
venous drug users.  The interpretation of the results of the 
nontreponemal tests depends on the population being tested. 
The predictive value of the nontreponemal tests is increased 
when combined with a reactive treponemal test.  Therefore, 
when the nontreponemal tests are used as screening tests in a 
low-risk population, all reactive results should be confirmed 
with a treponemal test.  In some low-risk populations, every 
reactive result may be a false-positive result (12).
 False-positive reactions occurring with the nontrepone-
mal tests can be divided into two groups: those that are acute 
false-positive reactions of <6 months in duration and those 
that are chronic false-positive reactions that persist for >6 
months (8, 9).  Acute false-positive nontreponemal reactions 
have been associated with hepatitis, infectious mononucleosis, 
viral pneumonia, chicken pox, measles, other viral infections, 
malaria, immunizations, pregnancy, tuberculosis, Lyme di-
sease, neoplasm, HIV infection and laboratory or technical 
error (4, 5, 8).
Chronic false-positive reactions have been associa-
ted with connective tissue diseases, such as systemic lupus 
erythematosus or diseases associated with immunoglobulin 
abnormalities, which are more common in women; thus, 
chronic false-positive reactions are more common in women 
than in men.  Other conditions associated with chronic false-
positive reactions are narcotic addiction, aging, leprosy and 
malignancy.  Generally, up to 90% of false-positive reactions 
have a titer of less than 1:8, and reactive nontreponemal 
tests with titers less than 1:8 and subsequent nonreactive 
treponemal tests are considered to be biological false-positive 
reactions.
The titer of false-positive reactions is usually low, but 
on rare occasions it can be extremely high; therefore, the 
quantitative titer cannot be used to differentiate between a 
false-positive reaction and syphilis.  This is especially true for 
persons who inject illegal drugs.  More than 10% of intraveno-
us drug users have false positive test results with titers less than 
1:8.  Chronic false-positive reactions persist for more than six 
months and are often associated with autoimmune disorders 
and chronic inflammatory conditions (4, 6, 8, 11).
The problem is complicated because false-positive re-
actions can also occur with treponemal tests.
The specificity of the FTA-abs (fluorescent treponemal an-
tibody) is also poorer than that of the other treponemal tests.
Approximately 1-2% of the normal population will show 
a false positive FTA-abs result.  False positives have also been 
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reported with narcotic addiction, autoimmune haemolytic 
anaemia, some viral infections and in the elderly (5).
The TPHA test is highly sensitive in all stages of the 
disease except, possibly, in early primary syphilis.  It also 
has very high specificity with as few as 1.5% false positives. 
These false positives have been reported in some patients with 
infectious mononucleosis, connective tissue diseases, leprosy 
and with intravenous drug use.  The EIA can be false positive 
in LES, neoplasmes, leprosy, rheumatoid arthritis.  The non-
recognition of serological false-positive tests for syphilis may 
have negative prognostic and social implications.  Therefore, 
careful clinical interpretation of test results and other evi-
dence is necessary for proper diagnosis.  Significant research 
advances in recent years have influenced the management of 
patients with syphilis.
The ideal test for syphilis should have both high sensi-
tivity and specificity, be suitable for monitoring response to 
treatment, give a negative result after adequate therapy and 
also give a clear indication of reinfection.  Unfortunately, such 
a test does not exist. Instead a combination of tests must be 
used (14).  Technological advances have resulted in improved 
serodiagnostic tools for syphilis.
The Western blot (WB) method has been used for the 
past 15 years to investigate the immune response to individual 
Treponema pallidum antigens in sera from experimentally 
infected animals and from humans with naturally occurring 
syphilis.
Immunoblotting allows for the detection of antibodies to 
individual proteins. In the Treponemal Western blot, solubili-
zed T.pallidum proteins are separated by gel-electrophoresis 
according to their molecular size.  The separated proteins 
are then transferred onto a nitrocellulose membrane which 
is dried and cut into strips.  After incubating the strips with 
patient’s serum, antigen-antibody complexes are visualized by 
adding enzyme-conjugated anti-human globulin followed by 
substrate, which causes a color reaction.  It is generally agreed 
that detection of antibodies to immunodeterminants with 
molecular masses of 15, 17, 44.5 and 47kDa are diagnostic 
for acquired syphilis (3, 9, 14).  A recent development is the 
use of recombinant antigens instead of fractionated proteins. 
The use of recombinant antigens could avoid the difficulties 
in purifying specific T. pallidum proteins due to the complex 
antigenic structure of this spirochete, and it has the potential to 
increase the specificity of serologic investigations (3, 7, 9).
Currently the Treponemal Western Blot Test is a con-
firmation test for syphilis.  It is not intended to be used for 
routine confirmation, but is reserved for situations where 
the clinical picture and other serological test results do not 
give a clear status of infection.  The western blot has highest 
specificity and sensibility in all stage of syphilis (2, 7, 9).  The 
IgG immunoblot using recombinant antigen is recommen-
ded as supplementary confirmatory test when a positive EIA 
screening test is not confirmed by the TPPA (TPHA) test or 
when a positive TPPA (TPHA) screening test is not confirmed 
by the EIA test (2).
Finally, we would like to present our cases of personal 
medical practice.
Patient N., 71 years old, is suffering from hepatitis C, 
hepatitis B and rheumatoid arthritis.  He had no evidence of 
clinical symptoms or history of syphilis.  His wife’s serological 
studies for syphilis were negative.  He had the RMP 1:8 titer, 
EIA weakly reactive, TPHA 1:80,WB negative.  We diagnosed 
the false-positive test for syphilis in this patient.
Patient K., 20 years old, virgin, is suffering from rheu-
matism.  He had no evidence of clinical symptoms or history 
of syphilis.  He had RW 4+ 1: 5 titer. RMP1:3 titer, TPHA 1:80, 
WB negative, ELISA negative.  We diagnosed the false-positive 
test for syphilis in this patient.
Patient W., 53 years old, is suffering from prostate can-
cer with metastasis.  His wife’s serological studies for syphilis 
were negative.  He had no evidence of clinical symptoms or 
history of syphilis.  RMP 4+ 1:3 titer, RW 4+ 1:10, TPHA and 
EIA weakly positive.  We diagnosed the false-positive test for 
syphilis in this patient.
Patient R., 24 years old, is pregnant, suffering from hepa-
titis B and genital herpes.  Her husband’s serological studies for 
syphilis were negative.  He had no evidence of clinical symp-
toms or history of syphilis.  Serological tests: RW3+, RMP3+, 
TPHA negative, EIA reactive, WB negative.  We diagnosed 
the false-positive test for syphilis in this patient.
Patient Z., 49 years old, suffering from diabetes, chronic 
renal insufficiency and is on hemodialysis.  He had no evi-
dence of clinical symptoms or history of syphilis.  His wife’s 
serological studies for syphilis were negative.  Serological 
results: RW4+ 1:10, RMP 4+1:4, TPHA, EIA reactive, WB 
negative.  We diagnosed the false-positive test for syphilis in 
this patient.
Patient X., 35 years old, is suffering from Lyme disease. 
He had no evidence of clinical symptoms or history of syphi-
lis.  His sexual partner’s serological studies for syphilis were 
negative.  Serological tests results: RW 4+1:10, RMP4+1:4, 
EIA, TPHA reactive, WB negative, Lyme test titer positive.  We 
diagnosed the false-positive test for syphilis in this patient.
In conclusion, serologic tests provide only indirect 
evidence of syphilis and may be reactive in the absence of 
clinical, historical or epidemiologic evidence of syphilis, and 
are, therefore, very important for the laboratory diagnosis to 
be as reliable as possible.  We can conclude that many of the 
false-positive reactions can be resolved using the Western-
blot assay and its use can improve the reliability of syphilis 
serology.
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